Moderna will continue to lead clinical development and manufacturing for mRNA-3927Moderna to receive up to $160 million ...
The team applied this method to mRNA/saRNA constructs from 1 to 10 kb and assessed pH ranges from 3 to 6. For all the RNA constructs, the J2 immunoblot signal—a marker for dsRNA strands—decreased with ...
CAMBRIDGE, MA / ACCESS Newswire / November 19, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced the expansion of its U.S. manufacturing capabilities with the onshoring of Drug Product manufacturing ...
Newly accredited GMP facility for commercial manufacturing of mRNA in anticipation of customer BLA submission. Kaneka Eurogentec, an FDA, EMA inspected CDMO focused on the production of injectable ...
Moderna (NASDAQ:MRNA) has cancelled plans to build a messenger RNA manufacturing plant in Japan, citing concerns over the current business environment, the Japanese business publication Nikkei Asia ...
New capabilities strengthen U.S. production, completing Moderna’s domestic end-to-end mRNA manufacturing network More than $140 million investment will create hundreds of highly skilled ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results